Entry Detail



General Information

Database ID:exR0359458
RNA Name:AFAP1
RNA Type:mRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):7758714End Site(bp):7939926
External Links:ENSG00000196526



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
RAPGEF1
chr9
131576770
131740074
-
PGAM1
chr10
97426191
97433444
+
RBX1
chr22
40951347
40973309
+
ZNF462
chr9
106863166
107013634
+
DKC1
chrX
154762742
154777689
+
PA2G4
chr12
56104537
56113910
+
NCL
chr2
231453531
231483641
-
LAMTOR2
chr1
156054782
156058506
+
GAPDH
chr12
6534512
6538374
+
EXOSC4
chr8
144078648
144080648
+
RPS14
chr5
150442635
150449739
-
WDR46
chr6
33279108
33289247
-
TCP1
chr6
159778498
159789703
-
PITX2
chr4
110617423
110642123
-
FNDC3A
chr13
48975912
49209779
+
PFN1
chr17
4945652
4949061
-
FKBP1A
chr20
1368978
1393172
-
HS6ST1
chr2
128236716
128318868
-
DTL
chr1
212035553
212107400
+
TNIK
chr3
171058414
171460408
-
GDAP1
chr8
74321130
74488872
+
ACOX3
chr4
8366282
8440723
-
YME1L1
chr10
27110112
27155266
-
ERP29
chr12
112013348
112023449
+
MT-CO1
chrMT
5904
7445
+
PABPC4
chr1
39560816
39576790
-
MT-ND2
chrMT
4470
5511
+
BOD1
chr5
173607145
173616659
-
NUCKS1
chr1
205712822
205750182
-
SPG7
chr16
89490719
89557768
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-193a-3p
chr17
31560050
31560071
+
hsa-miR-485-5p
chr14
101055427
101055448
+
hsa-miR-193b-3p
chr16
14304017
14304038
+
hsa-miR-650
chr22
22822791
22822811
+
hsa-miR-423-5p
chr17
30117095
30117117
+
hsa-miR-664b-5p
chrX
154768596
154768619
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AL355987.4
chr9
136799223
136810042
+
SNHG14
chr15
24978583
25420336
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.